Improved tumor vascular function following high‐dose epidermal growth factor receptor tyrosine kinase inhibitor therapy

Abstract

These data suggest that HER family TKIs have the potential to optimize the tumor microenvironment for delivery of cytotoxic chemotherapeutics.